ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3

Li, Yaqin; Zhou, Tao; Cheng, Xianyi; Li, Dezhi; Zhao, Meng; Zheng, Wei, V*北京大学; 南方医科大学
Bioengineered2022-3-1DOI: 10.1080/21655979.2022.2031408
14被引6阅读
引用收藏
分享

摘要

Programmed death ligand 1 (PD-L1) plays an essential role in the development or progression of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression during normal and pathophysiological events. Here, we explored the functions and detailed mechanisms of miR-378a-3p and PD-L1 in HCC progression. First, miR-378a-3p was selected by analyzing miRNA levels in two HCC Gene Expression Omnibus datasets. We found that miR-378a-3p levels exhibited a downward trend in HCC and were negatively correlated with PD-L1 levels. Additionally, a dual luciferase assay predicted that miR-378a-3p directly targets PD-L1. Moreover, the transfection of miR-378a-3p mimics into Li-7 and HuH-7 cells effectively decreased the PD-L1 mRNA and protein expression levels, and inhibited Treg differentiation in co-culture models by modulating the expression levels of certain cytokines. Furthermore, the overexpression of miR-378a-3p hindered cell proliferation and migration but facilitated apoptosis by repressing STAT3 signaling in HCC cells. In conclusion, miR-378a-3p appears to inhibit HCC tumorigenesis by regulating PD-L1 and STAT3 levels. Thus, miR-378a-3p may be a potential target for HCC therapy.

学科与关键词

关键词
Hepatocellular carcinomamiR-378a-3pPD-L1immune escapeSTAT3
相关
加载中…
  • miRNA-518a-3p Inhibits Hepatocarcinogenesis by Down-Regulating ZNF281
    Chen, Diandian; Shi, Kezhi*; Hu, Yili*JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37(8): 4377-4385.
  • Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma
    Zhao, Yi; Li, Meizhang; Miao, Nana; Wei, Wei; Dong, Yulong; Tao, Chenjie; Chen, Jinzhong; Pei, Yongyan*; Guo, Lieping*Frontiers in Genetics, 2022, 13: 819553.
  • The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells
    Liu, Zongcai; Ning, Fen; Cai, Yanna; Sheng, Huiying; Zheng, Ruidan; Yin, Xi; Lu, Zhikun; Su, Ling; Chen, Xiaodan; Zeng, Chunhua; Wang, Haifang*; Liu, Li*Cancer Communications, 2021, 41(1): 62-78.被引 26
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioengineered
发表日期
2022-03-01
卷期
第 13 卷, 第 3 期
页码
4730-4743
DOI
10.1080/21655979.2022.2031408
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Sanming Project of Medicine in Shenzhen [SZSM201612071]; Shenzhen Key Medical Discipline Construction Fund [SZXK078]; Cell Technology Center and Transformation Base, Innovation Center of GuangdongHong Kong-Macao Greater Bay Area, Ministry of Science and Technology of China [YCZYPT[2018]03-1]; Scientific Research Foundation of PEKING UNIVERSITY SHENZHEN HOSPITAL [KYQD202100X]

作者

  • L

    Li, Yaqin (第一作者)

    peking univ shenzhen

  • Z

    Zhou, Tao

    peking univ shenzhen

查看全部 6 位作者收起作者
  • C

    Cheng, Xianyi

    peking univ shenzhen

  • L

    Li, Dezhi

    peking univ shenzhen

  • Z

    Zhao, Meng

    2 · southern med univ

  • Z

    Zheng, Wei, V (通讯)

    peking univ shenzhen

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417